Stefan Günther

Stefan Günther

Auto-generated profile, based on publicly available information

Stefan Günther

Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2023 in Nature
Verified
Journal Article
Open access
PDF file
XLXiang Li
Xiang Li
FWFan Wu
Fan Wu
SGStefan Günther
Stefan Günther
MLMario Looso
Mario Looso
CKCarsten Kuenne
Carsten Kuenne
TBThomas Braun
Thomas Braun
Postnatal maturation of cardiomyocytes is characterized by a metabolic switch from glycolysis to fatty acid oxidation, chromatin reconfiguration and exit from the cell cycle, instating a barrier for adult heart regeneration 1,2 . Here, to explore whether metabolic reprogramming can overcome this barrier and enable heart regeneration, we abrogate fatty acid oxidation in cardiomyocytes by inactivation of Cpt1b . We find that disablement of fatty acid oxidation in cardiomyocytes improves resistance to hypoxia and stimulates cardiomyocyte proliferation, allowing heart regeneration after ischaemia–reperfusion injury. Metabolic studies reveal profound changes in energy metabolism and accumulation of α-ketoglutarate in Cpt1b -mutant cardiomyocytes, leading to activation of the α-ketoglutarate-dependent lysine demethylase KDM5 (ref. 3 ). Activated KDM5 demethylates broad H3K4me3 domains in genes that drive cardiomyocyte maturation, lowering their transcription levels and shifting cardiomyocytes into a less mature state, thereby promoting proliferation. We conclude that metabolic maturation shapes the epigenetic landscape of cardiomyocytes, creating a roadblock for further cell divisions. Reversal of this process allows repair of damaged hearts.

23 September 2020 in Cardiovascular Research
Verified
Journal Article
Closed access
DBDenisa Bojkova
Denisa Bojkova
JWJulian U G Wagner
Julian U G Wagner
MSMariana Shumliakivska
Mariana Shumliakivska
GAGalip S Aslan
Galip S Aslan
USUmber Saleem
Umber Saleem
DBDittmar Böckler
Dittmar Böckler
Aims: Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has emerged as a global pandemic. SARS-CoV-2 infection can lead to elevated markers of cardiac injury associated with higher risk of mortality. It is unclear whether cardiac injury is caused by direct infection of cardiomyocytes or is mainly secondary to lung injury and inflammation. Here, we investigate whether cardiomyocytes are permissive for SARS-CoV-2 infection. Methods and results: Two strains of SARS-CoV-2 infected human induced pluripotent stem cell-derived cardiomyocytes as demonstrated by detection of intracellular double-stranded viral RNA and viral spike glycoprotein expression. Increasing concentrations of viral RNA are detected in supernatants of infected cardiomyocytes, which induced infections in Caco-2 cell lines, documenting productive infections. SARS-CoV-2 infection and induced cytotoxic and proapoptotic effects associated with it abolished cardiomyocyte beating. RNA sequencing confirmed a transcriptional response to viral infection as demonstrated by the up-regulation of genes associated with pathways related to viral response and interferon signalling, apoptosis, and reactive oxygen stress. SARS-CoV-2 infection and cardiotoxicity was confirmed in a 3D cardiosphere tissue model. Importantly, viral spike protein and viral particles were detected in living human heart slices after infection with SARS-CoV-2. Coronavirus particles were further observed in cardiomyocytes of a patient with coronavirus disease 2019. Infection of induced pluripotent stem cell-derived cardiomyocytes was dependent on cathepsins and angiotensin-converting enzyme 2, and was blocked by remdesivir. Conclusion: This study demonstrates that SARS-CoV-2 infects cardiomyocytes in vitro in an angiotensin-converting enzyme 2- and cathepsin-dependent manner. SARS-CoV-2 infection of cardiomyocytes is inhibited by the antiviral drug remdesivir.

17 June 2019 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
AIAndras Iring
Andras Iring
YJYoung-June Jin
Young-June Jin
Julián Albarrán-JuárezJulián Albarrán-Juárez
Julián Albarrán-Juárez
MSMauro Siragusa
Mauro Siragusa
SWShengPeng Wang
ShengPeng Wang
SOStefan Offermanns
Stefan Offermanns
Hypertension is a primary risk factor for cardiovascular diseases including myocardial infarction and stroke. Major determinants of blood pressure are vasodilatory factors such as nitric oxide (NO) released from the endothelium under the influence of fluid shear stress exerted by the flowing blood. Several endothelial signaling processes mediating fluid shear stress–induced formation and release of vasodilatory factors have been described. It is, however, still poorly understood how fluid shear stress induces these endothelial responses. Here we show that the endothelial mechanosensitive cation channel PIEZO1 mediated fluid shear stress–induced release of adrenomedullin, which in turn activated its Gs-coupled receptor. The subsequent increase in cAMP levels promoted the phosphorylation of endothelial NO synthase (eNOS) at serine 633 through protein kinase A (PKA), leading to the activation of the enzyme. This Gs/PKA-mediated pathway synergized with the AKT-mediated pathways leading to eNOS phosphorylation at serine 1177. Mice with endothelium-specific deficiency of adrenomedullin, the adrenomedullin receptor, or Gαs showed reduced flow-induced eNOS activation and vasodilation and developed hypertension. Our data identify fluid shear stress–induced PIEZO1 activation as a central regulator of endothelial adrenomedullin release and establish the adrenomedullin receptor and subsequent Gs-mediated formation of cAMP as a critical endothelial mechanosignaling pathway regulating basal endothelial NO formation, vascular tone, and blood pressure.

26 April 2019 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
ISIsabelle Salwig
Isabelle Salwig
BSBirgit Spitznagel
Birgit Spitznagel
AVAna Ivonne Vazquez-Armendariz
Ana Ivonne Vazquez-Armendariz
KKKeynoosh Khalooghi
Keynoosh Khalooghi
SGStefan Guenther
Stefan Guenther
TBThomas Braun
Thomas Braun
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

5 June 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
PSPoonam Sarode
Poonam Sarode
XZXiang Zheng
Xiang Zheng
GGGeorgia A. Giotopoulou
Georgia A. Giotopoulou
Andreas WeigertAndreas Weigert
Andreas Weigert
CKCarste Kuenne
Carste Kuenne
Rajkumar SavaiRajkumar Savai
Rajkumar Savai
Targeting β-catenin–dependent gene regulation in macrophages may offer a new immunotherapeutic option in lung cancer.

25 August 2023 in Science
Verified
Journal Article
Closed access
JWJulian Wagner
Julian Wagner
LTLukas S. Tombor
Lukas S. Tombor
PMPedro Felipe Malacarne
Pedro Felipe Malacarne
LKLisa-Maria Kettenhausen
Lisa-Maria Kettenhausen
JPJosefine Panthel
Josefine Panthel
DBDittmar Böckler
Dittmar Böckler
Aging is a major risk factor for impaired cardiovascular health. Because the aging myocardium is characterized by microcirculatory dysfunction, and because nerves align with vessels, we assessed the impact of aging on the cardiac neurovascular interface. We report that aging reduces nerve density in the ventricle and dysregulates vascular-derived neuroregulatory genes. Aging down-regulates microRNA 145 (miR-145) and derepresses the neurorepulsive factor semaphorin-3A. miR-145 deletion, which increased Sema3a expression or endothelial Sema3a overexpression, reduced axon density, mimicking the aged-heart phenotype. Removal of senescent cells, which accumulated with chronological age in parallel to the decline in nerve density, rescued age-induced denervation, reversed Sema3a expression, preserved heart rate patterns, and reduced electrical instability. These data suggest that senescence-mediated regulation of nerve density contributes to age-associated cardiac dysfunction.